Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1033 | 1078 | 1132 | 1262 | 1726 | 2248 |
Fund Return | 3.34% | 7.82% | 13.16% | 8.07% | 11.53% | 8.44% |
Place in category | 274 | 356 | 132 | 339 | 69 | 99 |
% in Category | 38 | 51 | 16 | 61 | 11 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Continental European Equity Class G | 1B | 8.43 | 7.24 | 9.22 | ||
Continental European Equity ClassGA | 1B | 3.42 | 8.61 | 8.95 | ||
Continental European Equity ClassGI | 1B | 3.42 | 8.60 | 8.95 | ||
European Equity Class GBP Accumulat | 573.71M | 3.05 | 7.26 | 8.48 | ||
European Equity Class GBP Income | 573.71M | 3.05 | 7.26 | 8.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
iShares Continental Europe Eq D Acc | 6.34B | 5.28 | 7.35 | 8.27 | ||
GB00BJL5BS14 | 6.34B | 5.28 | 7.36 | 8.28 | ||
Continental European Flexible Fundg | 5.79M | 8.63 | 5.62 | 12.35 | ||
European Dynamic Fund D Accumulatio | 4.59B | 8.26 | 5.06 | 11.57 | ||
European Dynamic Fund D Income | 4.59B | 8.26 | 5.05 | 11.56 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.39 | 916.2 | -1.19% | |
UniCredit | IT0005239360 | 4.35 | 36.035 | -1.27% | |
Inditex | ES0148396007 | 4.13 | 43.750 | +1.02% | |
Atlas Copco A | SE0017486889 | 4.06 | 202.8 | +1.65% | |
Linde PLC | IE000S9YS762 | 4.03 | 399.000 | -0.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review